Monday, December 6, 2021

Pharma Reviews: Diabetes major Eris Lifesciences enters India's insulin market through joint venture with MJ ...

Eris, one of India's leading players in the Oral Diabetes Care segment, will now extend its product offering to insulins and GLP1 agonists.
Read more: Diabetes major Eris Lifesciences enters India's insulin market through joint venture with MJ ...